Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-21-034018

Options or other derivatives

  • President & CEO acquired 70,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tesi Raymond Joseph President & CEO 2021-06-22 Grant or award · Option +70,663 70,663 D
Loading xslF345X03/ownership.xml…